Mar 24, 2009
Drug regulators must make the morning-after pill available over the counter to girls as young as age 17, a federal judge in New York ruled yesterday, suggesting that the Food and Drug Administration (FDA) consider making the medication accessible to younger girls, as well.
U.S. District Judge Edward Korman said the FDA has 30 days to comply with his decision. He said that delays in approving the drug, Barr Pharmaceuticals’ Plan B, for non-prescription sale were “repeated and unreasonable,” and that the agency's decisions about the drug, including limiting it to women 18 and older, were “arbitrary and capricious.”
Deadline: Dec 11 2013
Reward: $52,000 USD
Platform technologies – tools, techniques, and instruments that enable entirely novel approaches for scientific investigation across a b
Give a 1 year subscription as low as $14.99X